We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX (IEX) Q1 Earnings Top Estimates, Revenues Increase
Read MoreHide Full Article
IDEX Corporation (IEX - Free Report) reported better-than-expected results for the first quarter of 2019. It pulled off a positive earnings surprise of 5.11%.
The company’s adjusted earnings per share were $1.44, surpassing the Zacks Consensus Estimate of $1.37.
Further, the bottom line increased 12% from the year-ago quarter figure of $1.29. The improvement was driven by healthy organic growth and diligent execution of productivity initiatives.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX generated revenues of $622.2 million in the quarter under review, reflecting year-over-year growth of 2%. The top-line improvement came on the back of 4% growth in organic sales, partially offset by 2% adverse impact of forex woes.
However, the top line lagged the consensus estimate of $635 million by 2%.
In the first quarter, orders increased 4% year over year to $655.5 million. As noted, organically orders improved 6%, acquisitions had positive impact of 1% and foreign currency movements had an adverse 3% impact.
IDEX reports revenues under the segments discussed below:
Net sales of Fluid & Metering Technologies (“FMT”) were $242.5 million, up 4% year over year. Organic net sales grew 6% while forex headwinds had 2% impact.
Revenues from Health & Science Technologies (“HST”) totaled $225.3 million, reflecting year-over-year growth of 2%. Results were driven by 3% organic sales growth and 1% gain from acquisitions, partially offset by forex woes of 2%.
Fire & Safety/Diversified Products (“FSDP”) revenues were $156.2 million, down 2% from the year-ago quarter. Organic sales improved 1% while currency translation had adverse 3% impact.
Margin Details
In the reported quarter, IDEX’s cost of sales increased 0.8% year over year to $338.4 million. It represented 55.4% of the quarter’s revenues compared with 54.8% in the year-ago quarter. Gross margin improved 40 basis points (bps) to 45.6% on the back of benefits from higher volumes, pricing and productivity actions. However, rise in engineering costs played spoilsport. Selling, general and administrative expenses decreased marginally to $136.5 million. It represented 21.9% of revenues compared with 22.5% a year ago.
Adjusted operating income increased 8.1% to $147.8 million, and margin improved 120 bps to 23.8%. On a segmental basis, adjusted operating income for the FMT segment increased 8.4% to $71.9 million and that for HST expanded 2.5% to $54.2 million while for FSDP it increased 1.5% to $40.3 million. Adjusted effective tax rate in the reported quarter was 19.5%.
Balance Sheet and Cash Flow
Exiting the first quarter, IDEX had cash and cash equivalents of $456.1 million, down 2.3% from $466.4 million recorded at the end of the last reported quarter. Long-term borrowings were flat sequentially at $848.4 million.
In the first quarter, the company generated net cash of $88.7 million from operating activities, reflecting growth of 23.7% from the year-ago quarter. Free cash flow was $75.8 million, up 23%.
Outlook
For 2019, adjusted earnings are anticipated to be $5.70-$5.85, higher than $5.60-$5.80 per share guided earlier. Organic revenue growth is estimated to be roughly 4-5%.
For the second quarter, earnings per share are expected to be $1.47-$1.50.
DXP Enterprises delivered average earnings surprise of 46.55% in the trailing four quarters.
Actuant pulled off average positive earnings surprise of 11.01% in the trailing four quarters.
Cintas outpaced estimates in the last reported quarter by 6.09%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
IDEX (IEX) Q1 Earnings Top Estimates, Revenues Increase
IDEX Corporation (IEX - Free Report) reported better-than-expected results for the first quarter of 2019. It pulled off a positive earnings surprise of 5.11%.
The company’s adjusted earnings per share were $1.44, surpassing the Zacks Consensus Estimate of $1.37.
Further, the bottom line increased 12% from the year-ago quarter figure of $1.29. The improvement was driven by healthy organic growth and diligent execution of productivity initiatives.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation Price, Consensus and EPS Surprise | IDEX Corporation Quote
IDEX generated revenues of $622.2 million in the quarter under review, reflecting year-over-year growth of 2%. The top-line improvement came on the back of 4% growth in organic sales, partially offset by 2% adverse impact of forex woes.
However, the top line lagged the consensus estimate of $635 million by 2%.
In the first quarter, orders increased 4% year over year to $655.5 million. As noted, organically orders improved 6%, acquisitions had positive impact of 1% and foreign currency movements had an adverse 3% impact.
IDEX reports revenues under the segments discussed below:
Net sales of Fluid & Metering Technologies (“FMT”) were $242.5 million, up 4% year over year. Organic net sales grew 6% while forex headwinds had 2% impact.
Revenues from Health & Science Technologies (“HST”) totaled $225.3 million, reflecting year-over-year growth of 2%. Results were driven by 3% organic sales growth and 1% gain from acquisitions, partially offset by forex woes of 2%.
Fire & Safety/Diversified Products (“FSDP”) revenues were $156.2 million, down 2% from the year-ago quarter. Organic sales improved 1% while currency translation had adverse 3% impact.
Margin Details
In the reported quarter, IDEX’s cost of sales increased 0.8% year over year to $338.4 million. It represented 55.4% of the quarter’s revenues compared with 54.8% in the year-ago quarter. Gross margin improved 40 basis points (bps) to 45.6% on the back of benefits from higher volumes, pricing and productivity actions. However, rise in engineering costs played spoilsport. Selling, general and administrative expenses decreased marginally to $136.5 million. It represented 21.9% of revenues compared with 22.5% a year ago.
Adjusted operating income increased 8.1% to $147.8 million, and margin improved 120 bps to 23.8%. On a segmental basis, adjusted operating income for the FMT segment increased 8.4% to $71.9 million and that for HST expanded 2.5% to $54.2 million while for FSDP it increased 1.5% to $40.3 million. Adjusted effective tax rate in the reported quarter was 19.5%.
Balance Sheet and Cash Flow
Exiting the first quarter, IDEX had cash and cash equivalents of $456.1 million, down 2.3% from $466.4 million recorded at the end of the last reported quarter. Long-term borrowings were flat sequentially at $848.4 million.
In the first quarter, the company generated net cash of $88.7 million from operating activities, reflecting growth of 23.7% from the year-ago quarter. Free cash flow was $75.8 million, up 23%.
Outlook
For 2019, adjusted earnings are anticipated to be $5.70-$5.85, higher than $5.60-$5.80 per share guided earlier. Organic revenue growth is estimated to be roughly 4-5%.
For the second quarter, earnings per share are expected to be $1.47-$1.50.
Zacks Rank & Key Picks
IDEX currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the same space are DXP Enterprises, Inc. (DXPE - Free Report) , Actuant Corporation and Cintas Corporation (CTAS - Free Report) . While DXP Enterprises sports a Zacks Rank #1 (Strong Buy), Actuant and Cintas carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DXP Enterprises delivered average earnings surprise of 46.55% in the trailing four quarters.
Actuant pulled off average positive earnings surprise of 11.01% in the trailing four quarters.
Cintas outpaced estimates in the last reported quarter by 6.09%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>